Literature DB >> 30397101

mRNA decapping: finding the right structures.

Clément Charenton1, Marc Graille2.   

Abstract

In eukaryotes, the elimination of the m7GpppN mRNA cap, a process known as decapping, is a critical, largely irreversible and highly regulated step of mRNA decay that withdraws the targeted mRNAs from the pool of translatable templates. The decapping reaction is catalysed by a multi-protein complex formed by the Dcp2 catalytic subunit and its Dcp1 cofactor, a holoenzyme that is poorly active on its own and needs several accessory proteins (Lsm1-7 complex, Pat1, Edc1-2, Edc3 and/or EDC4) to be fully efficient. Here, we discuss the several crystal structures of Dcp2 domains bound to various partners (proteins or small molecules) determined in the last couple of years that have considerably improved our current understanding of how Dcp2, assisted by its various activators, is recruited to its mRNA targets and adopts its active conformation upon substrate recognition. We also describe how, over the years, elegant integrative structural biology approaches combined to biochemistry and genetics led to the identification of the correct structure of the active Dcp1-Dcp2 holoenzyme among the many available conformations trapped by X-ray crystallography.This article is part of the theme issue '5' and 3' modifications controlling RNA degradation'.
© 2018 The Author(s).

Entities:  

Keywords:  cap recognition; mRNA decapping; multi-protein complexes

Mesh:

Substances:

Year:  2018        PMID: 30397101      PMCID: PMC6232594          DOI: 10.1098/rstb.2018.0164

Source DB:  PubMed          Journal:  Philos Trans R Soc Lond B Biol Sci        ISSN: 0962-8436            Impact factor:   6.237


  89 in total

1.  Multiple processing body factors and the ARE binding protein TTP activate mRNA decapping.

Authors:  Martin Fenger-Grøn; Christy Fillman; Bodil Norrild; Jens Lykke-Andersen
Journal:  Mol Cell       Date:  2005-12-22       Impact factor: 17.970

2.  Structural basis for the mutually exclusive anchoring of P body components EDC3 and Tral to the DEAD box protein DDX6/Me31B.

Authors:  Felix Tritschler; Joerg E Braun; Ana Eulalio; Vincent Truffault; Elisa Izaurralde; Oliver Weichenrieder
Journal:  Mol Cell       Date:  2009-03-13       Impact factor: 17.970

3.  Structural basis of the PNRC2-mediated link between mrna surveillance and decapping.

Authors:  Tingfeng Lai; Hana Cho; Zhou Liu; Matthew W Bowler; Shunfu Piao; Roy Parker; Yoon Ki Kim; Haiwei Song
Journal:  Structure       Date:  2012-10-18       Impact factor: 5.006

4.  Role of the essential yeast protein PSU1 in p6anscriptional enhancement by the ligand-dependent activation function AF-2 of nuclear receptors.

Authors:  C Gaudon; P Chambon; R Losson
Journal:  EMBO J       Date:  1999-04-15       Impact factor: 11.598

5.  P-Body Purification Reveals the Condensation of Repressed mRNA Regulons.

Authors:  Arnaud Hubstenberger; Maïté Courel; Marianne Bénard; Sylvie Souquere; Michèle Ernoult-Lange; Racha Chouaib; Zhou Yi; Jean-Baptiste Morlot; Annie Munier; Magali Fradet; Maëlle Daunesse; Edouard Bertrand; Gérard Pierron; Julien Mozziconacci; Michel Kress; Dominique Weil
Journal:  Mol Cell       Date:  2017-09-28       Impact factor: 17.970

6.  An essential component of the decapping enzyme required for normal rates of mRNA turnover.

Authors:  C A Beelman; A Stevens; G Caponigro; T E LaGrandeur; L Hatfield; D M Fortner; R Parker
Journal:  Nature       Date:  1996-08-15       Impact factor: 49.962

7.  Identification and analysis of the interaction between Edc3 and Dcp2 in Saccharomyces cerevisiae.

Authors:  Yuriko Harigaya; Brittnee N Jones; Denise Muhlrad; John D Gross; Roy Parker
Journal:  Mol Cell Biol       Date:  2010-01-19       Impact factor: 4.272

8.  Degradation of YRA1 Pre-mRNA in the cytoplasm requires translational repression, multiple modular intronic elements, Edc3p, and Mex67p.

Authors:  Shuyun Dong; Allan Jacobson; Feng He
Journal:  PLoS Biol       Date:  2010-04-27       Impact factor: 8.029

9.  The human Pat1b protein: a novel mRNA deadenylation factor identified by a new immunoprecipitation technique.

Authors:  Antonio Totaro; Fabrizio Renzi; Giorgio La Fata; Claudia Mattioli; Monika Raabe; Henning Urlaub; Tilmann Achsel
Journal:  Nucleic Acids Res       Date:  2010-09-17       Impact factor: 16.971

Review 10.  The role of disordered protein regions in the assembly of decapping complexes and RNP granules.

Authors:  Stefanie Jonas; Elisa Izaurralde
Journal:  Genes Dev       Date:  2013-12-15       Impact factor: 11.361

View more
  10 in total

1.  5' and 3' modifications controlling RNA degradation: from safeguards to executioners.

Authors:  Dominique Gagliardi; Andrzej Dziembowski
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2018-11-05       Impact factor: 6.237

2.  Dcp2 C-terminal cis-binding elements control selective targeting of the decapping enzyme by forming distinct decapping complexes.

Authors:  Feng He; Chan Wu; Allan Jacobson
Journal:  Elife       Date:  2022-05-23       Impact factor: 8.713

Review 3.  mRNA-based therapeutics: powerful and versatile tools to combat diseases.

Authors:  Shugang Qin; Xiaoshan Tang; Yuting Chen; Kepan Chen; Na Fan; Wen Xiao; Qian Zheng; Guohong Li; Yuqing Teng; Min Wu; Xiangrong Song
Journal:  Signal Transduct Target Ther       Date:  2022-05-21

4.  mRNA decapping is an evolutionarily conserved modulator of neuroendocrine signaling that controls development and ageing.

Authors:  Fivos Borbolis; John Rallis; George Kanatouris; Nikolitsa Kokla; Antonis Karamalegkos; Christina Vasileiou; Katerina M Vakaloglou; George Diallinas; Dimitrios J Stravopodis; Christos G Zervas; Popi Syntichaki
Journal:  Elife       Date:  2020-05-05       Impact factor: 8.140

Review 5.  Eukaryotic mRNA Decapping Activation.

Authors:  Elva Vidya; Thomas F Duchaine
Journal:  Front Genet       Date:  2022-03-23       Impact factor: 4.599

6.  The cytoplasmic LSm1-7 and nuclear LSm2-8 complexes exert opposite effects on Hepatitis B virus biosynthesis and interferon responses.

Authors:  Naimur Rahman; Jiazeng Sun; Zhili Li; Aryamav Pattnaik; Rodrigo Mohallem; Mengbo Wang; Majid Kazemian; Uma K Aryal; Ourania Andrisani
Journal:  Front Immunol       Date:  2022-08-09       Impact factor: 8.786

Review 7.  The Pivotal Role of Chemical Modifications in mRNA Therapeutics.

Authors:  Albert Liu; Xiao Wang
Journal:  Front Cell Dev Biol       Date:  2022-07-13

Review 8.  Mutations in genes encoding regulators of mRNA decapping and translation initiation: links to intellectual disability.

Authors:  Dominique Weil; Amélie Piton; Davor Lessel; Nancy Standart
Journal:  Biochem Soc Trans       Date:  2020-06-30       Impact factor: 5.407

9.  A Novel Proximity Biotinylation Assay Based on the Self-Associating Split GFP1-10/11.

Authors:  Aditi S Kesari; Uma K Aryal; Douglas J LaCount
Journal:  Proteomes       Date:  2020-12-02

Review 10.  mRNA Therapeutic Modalities Design, Formulation and Manufacturing under Pharma 4.0 Principles.

Authors:  Andreas Ouranidis; Theofanis Vavilis; Evdokia Mandala; Christina Davidopoulou; Eleni Stamoula; Catherine K Markopoulou; Anna Karagianni; Kyriakos Kachrimanis
Journal:  Biomedicines       Date:  2021-12-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.